Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.

Por Vasudevachari, M B, Zhang, Y M, Imamichi, H, Imamichi, T, Falloon, J, Salzman, N P
Publicado em 1996

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.

Por Zhang, Y M, Imamichi, H, Imamichi, T, Lane, H C, Falloon, J, Vasudevachari, M B, Salzman, N P
Publicado em 1997

Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

Por Falloon, J, Lavelle, J, Ogata-Arakaki, D, Byrne, A, Graziani, A, Morgan, A, Amantea, M A, Ownby, K, Polis, M, Davey, R T
Publicado em 1994

Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Por Kovacs, J A, Vasudevachari, M B, Easter, M, Davey, R T, Falloon, J, Polis, M A, Metcalf, J A, Salzman, N, Baseler, M, Smith, G E
Publicado em 1993

Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.

Por Davey, R T, Dewar, R L, Reed, G F, Vasudevachari, M B, Polis, M A, Kovacs, J A, Falloon, J, Walker, R E, Masur, H, Haneiwich, S E
Publicado em 1993

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.

Por Polis, M A, Spooner, K M, Baird, B F, Manischewitz, J F, Jaffe, H S, Fisher, P E, Falloon, J, Davey, R T, Kovacs, J A, Walker, R E
Publicado em 1995

Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.

Por Polis, M A, Piscitelli, S C, Vogel, S, Witebsky, F G, Conville, P S, Petty, B, Kovacs, J A, Davey, R T, Walker, R E, Falloon, J, Metcalf, J A, Craft, C, Lane, H C, Masur, H
Publicado em 1997

Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.

Por Davey, R T, Chaitt, D G, Reed, G F, Freimuth, W W, Herpin, B R, Metcalf, J A, Eastman, P S, Falloon, J, Kovacs, J A, Polis, M A, Walker, R E, Masur, H, Boyle, J, Coleman, S, Cox, S R, Wathen, L, Daenzer, C L, Lane, H C
Publicado em 1996